In the investigation of epithelial ovarian cancer (EOC), there is evidence demonstrating that ADM functions as an upstream regulatory molecule of VEGF and HIF-1α, thereby facilitating tumor angiogenesis through the upregulation of VEGF and HIF-1α expression [67,80]. This evidence concerns the gene HIF1A and ovarian carcinoma.